Global and Region Hospital-acquired Infection Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Hospital-acquired Infection Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital-acquired Infection Diagnosticsmarket, defines the market attractiveness level of Hospital-acquired Infection Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hospital-acquired Infection Diagnostics industry, describes the types of Hospital-acquired Infection Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital-acquired Infection Diagnostics market and the development prospects and opportunities of Hospital-acquired Infection Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital-acquired Infection Diagnostics market in Chapter 13.

    By Player:

    • Alere Inc

    • Hologic Inc

    • Daiichi Sankyo

    • Roche AG

    • Advan DX

    • Astrazeneca PLC

    • Cepheid Inc

    • Bayer Schering Pharma LLC

    • Becton Dickinson And Company

    • Abbott Laboratories

    By Type:

    • Instrument and Reagents

    • Consumables

    By End-User:

    • Hospital

    • Clinics

    • Ambulatory Surgery Centers (ASC)

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hospital-acquired Infection Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hospital-acquired Infection Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hospital-acquired Infection Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hospital-acquired Infection Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hospital-acquired Infection Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Hospital-acquired Infection Diagnostics Consumption (2017-2022)

    • 7.2 United States Hospital-acquired Infection Diagnostics Consumption (2017-2022)

    • 7.3 Europe Hospital-acquired Infection Diagnostics Consumption (2017-2022)

    • 7.4 China Hospital-acquired Infection Diagnostics Consumption (2017-2022)

    • 7.5 Japan Hospital-acquired Infection Diagnostics Consumption (2017-2022)

    • 7.6 India Hospital-acquired Infection Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Hospital-acquired Infection Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Hospital-acquired Infection Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Hospital-acquired Infection Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Hospital-acquired Infection Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Hospital-acquired Infection Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Hospital-acquired Infection Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Hospital-acquired Infection Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Hospital-acquired Infection Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Hospital-acquired Infection Diagnostics Consumption Forecast (2022-2028)

    9 Global Hospital-acquired Infection Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Hospital-acquired Infection Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Instrument and Reagents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Consumables Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hospital-acquired Infection Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ambulatory Surgery Centers (ASC) Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Hospital-acquired Infection Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Instrument and Reagents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Consumables Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ambulatory Surgery Centers (ASC) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hospital-acquired Infection Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hospital-acquired Infection Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hospital-acquired Infection Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hospital-acquired Infection Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hospital-acquired Infection Diagnostics Market Competitive Analysis

    • 14.1 Alere Inc

      • 14.1.1 Alere Inc Company Details

      • 14.1.2 Alere Inc Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Alere Inc Hospital-acquired Infection Diagnostics Product and Service

    • 14.2 Hologic Inc

      • 14.2.1 Hologic Inc Company Details

      • 14.2.2 Hologic Inc Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Hologic Inc Hospital-acquired Infection Diagnostics Product and Service

    • 14.3 Daiichi Sankyo

      • 14.3.1 Daiichi Sankyo Company Details

      • 14.3.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product and Service

    • 14.4 Roche AG

      • 14.4.1 Roche AG Company Details

      • 14.4.2 Roche AG Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Roche AG Hospital-acquired Infection Diagnostics Product and Service

    • 14.5 Advan DX

      • 14.5.1 Advan DX Company Details

      • 14.5.2 Advan DX Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Advan DX Hospital-acquired Infection Diagnostics Product and Service

    • 14.6 Astrazeneca PLC

      • 14.6.1 Astrazeneca PLC Company Details

      • 14.6.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product and Service

    • 14.7 Cepheid Inc

      • 14.7.1 Cepheid Inc Company Details

      • 14.7.2 Cepheid Inc Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cepheid Inc Hospital-acquired Infection Diagnostics Product and Service

    • 14.8 Bayer Schering Pharma LLC

      • 14.8.1 Bayer Schering Pharma LLC Company Details

      • 14.8.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product and Service

    • 14.9 Becton Dickinson And Company

      • 14.9.1 Becton Dickinson And Company Company Details

      • 14.9.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product and Service

    • 14.10 Abbott Laboratories

      • 14.10.1 Abbott Laboratories Company Details

      • 14.10.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hospital-acquired Infection Diagnostics

    • Figure Hospital-acquired Infection Diagnostics Picture

    • Table Global Hospital-acquired Infection Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital-acquired Infection Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital-acquired Infection Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hospital-acquired Infection Diagnostics Consumption by Country (2017-2022)

    • Figure United States Hospital-acquired Infection Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Hospital-acquired Infection Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Hospital-acquired Infection Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Hospital-acquired Infection Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Hospital-acquired Infection Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hospital-acquired Infection Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital-acquired Infection Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hospital-acquired Infection Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Instrument and Reagents Consumption and Growth Rate (2017-2022)

    • Figure Global Consumables Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgery Centers (ASC) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Instrument and Reagents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Consumables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgery Centers (ASC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hospital-acquired Infection Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hospital-acquired Infection Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table Alere Inc (Foundation Year, Company Profile and etc.)

    • Table Alere Inc Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alere Inc Hospital-acquired Infection Diagnostics Product and Service

    • Table Hologic Inc (Foundation Year, Company Profile and etc.)

    • Table Hologic Inc Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic Inc Hospital-acquired Infection Diagnostics Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Hospital-acquired Infection Diagnostics Product and Service

    • Table Roche AG (Foundation Year, Company Profile and etc.)

    • Table Roche AG Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche AG Hospital-acquired Infection Diagnostics Product and Service

    • Table Advan DX (Foundation Year, Company Profile and etc.)

    • Table Advan DX Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advan DX Hospital-acquired Infection Diagnostics Product and Service

    • Table Astrazeneca PLC (Foundation Year, Company Profile and etc.)

    • Table Astrazeneca PLC Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca PLC Hospital-acquired Infection Diagnostics Product and Service

    • Table Cepheid Inc (Foundation Year, Company Profile and etc.)

    • Table Cepheid Inc Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cepheid Inc Hospital-acquired Infection Diagnostics Product and Service

    • Table Bayer Schering Pharma LLC (Foundation Year, Company Profile and etc.)

    • Table Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product and Service

    • Table Becton Dickinson And Company (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson And Company Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Hospital-acquired Infection Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Hospital-acquired Infection Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.